Year-Long trial tests new schizophrenia medication
NCT ID NCT07459647
Summary
This study will test the long-term safety and effectiveness of the medication ML-007C-MA in adults with schizophrenia. About 500 participants will take the medication for 52 weeks while researchers monitor side effects and how well it controls symptoms. The goal is to see if this treatment can help manage schizophrenia over an extended period.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.